Vimarsana
Biggest News Aggregation in the World

Page 7 - Cellular Immune News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cellular Immune. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cellular Immune Today - Breaking & Trending Today

Oramed ends subject enrolment in Phase II trial of oral insulin for NASH - Vimarsana News

Oramed ends subject enrolment in Phase II trial of oral insulin for NASH

Oramed Pharmaceuticals concluded enrolment in a Phase II trial of oral insulin capsule, ORMD-0801, to treat non-alcoholic steatohepatitis.

Pfizer to halt new clinical trial initiations in Russia amid Ukraine crisis - Vimarsana News

Pfizer to halt new clinical trial initiations in Russia amid Ukraine crisis

Pfizer has announced that the company will not commence any new clinical trials in Russia amid the Ukraine crisis.

Can Russia cope without Taiwan's semiconductors? Investment Monitor - Vimarsana News

Can Russia cope without Taiwan's semiconductors? Investment Monitor

Russia is dependent on Taiwan's semiconductors for everything from the manufacture of laptops to military equipment.

How foreign companies are supporting Ukraine's fight - Vimarsana News

How foreign companies are supporting Ukraine's fight

Many foreign companies operating in Ukraine have swiftly moved to support the country as it defends itself from the Russian invasion.

Sanofi and GSK to seek approval for delayed Covid-19 vaccine - Vimarsana News

Sanofi and GSK to seek approval for delayed Covid-19 vaccine

The companies have reported positive study results after a series of delays to the Sanofi-GSK vaccine’s development.